Treatment-free remission of chronic myeloid leukemia in real-world practice by the detection limit of MR4.3.
Sign Up to like & getrecommendations! Published in 2021 at "Leukemia research"
DOI: 10.1016/j.leukres.2021.106578
Abstract: BACKGROUND Molecular response (MR) 4.0 or 4.3 remains an indicator of treatment-free remission (TFR) in patients with chronic myeloid leukemia (CML) in countries that accept it as the criterion of undetectable minimal residual disease (UMRD)… read more here.
Keywords: treatment free; treatment; mr4; free remission ... See more keywords